logo
welcome
Reuters

Reuters

British drugmaker GSK moves mRNA flu vaccine to late-stage trials

Reuters
Summary
Nutrition label

82% Informative

British drugmaker GSK announced positive results from a mid-stage trial of its seasonal influenza vaccine programme.

GSK said it would now progress to late-stage clinical development.

Vaccine candidate produced positive immune responses against both A and B flu strains in younger and older adults, compared with the current standard treatments.

VR Score

92

Informative language

98

Neutral language

65

Article tone

formal

Language

English

Language complexity

77

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links